Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights

Matinas BioPharma (MTNB) Reports In-Line Q4 EPS

March 8, 2022 6:33 AM EST

Matinas BioPharma (NYSE: MTNB) reported Q4 EPS of ($0.03), in-line with the analyst estimate of ($0.03).

For earnings history and earnings-related data on Matinas BioPharma (MTNB) click here.

... More